Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roy van der Meel

Showing results (11-20 of 57) with videos related to

Pageof 6
Sort By:
Analytica Chimica Acta|March 15, 2014
Capillary electrophoresis-based assessment of nanobody affinity and purityRob Haselberg, Sabrina Oliveira, Roy van der Meel, et al.
Cell Host & Microbe|November 9, 2023
Trained immunity: Target for prophylaxis and therapyAthanasios Ziogas, Mariolina Bruno, Roy van der Meel, et al.
Nature Nanotechnology|November 8, 2019
Smart cancer nanomedicineRoy van der Meel, Einar Sulheim, Yang Shi, et al.
Advanced Drug Delivery Reviews|July 5, 2020
Lipid nanoparticle technology for therapeutic gene regulation in the liverDominik Witzigmann, Jayesh A Kulkarni, Jerry Leung, et al.
Advanced Drug Delivery Reviews|July 30, 2020
Nuclear imaging approaches facilitating nanomedicine translationCarlos Pérez-Medina, Abraham J P Teunissen, Ewelina Kluza, et al.
Advanced Drug Delivery Reviews|September 11, 2013
Ligand-targeted particulate nanomedicines undergoing clinical evaluation: current statusRoy van der Meel, Laurens J C Vehmeijer, Robbert J Kok, et al.
Drug Discovery Today|December 29, 2009
Recent advances in molecular imaging biomarkers in cancer: application of bench to bedside technologiesRoy van der Meel, William M Gallagher, Sabrina Oliveira, et al.
Nanomedicine (London, England)|March 30, 2016
Cetuximab treatment alters the content of extracellular vesicles released from tumor cellsSusan M van Dommelen, Roy van der Meel, Wouter W van Solinge, et al.
Langmuir : the ACS Journal of Surfaces and Colloids|January 13, 2021
Characterization of Lipid Nanoparticles Containing Ionizable Cationic Lipids Using Design-of-Experiments ApproachTakeshi Terada, Jayesh A Kulkarni, Ariel Huynh, et al.
Nature Nanotechnology|July 1, 2021
Author Correction: The current landscape of nucleic acid therapeuticsJayesh A Kulkarni, Dominik Witzigmann, Sarah B Thomson, et al.
Pageof 6

Showing results (11-20 of 57) with videos related to

Sort By:
Pageof 6
Analytica Chimica Acta|March 15, 2014
Capillary electrophoresis-based assessment of nanobody affinity and purityRob Haselberg, Sabrina Oliveira, Roy van der Meel, et al.
Cell Host & Microbe|November 9, 2023
Trained immunity: Target for prophylaxis and therapyAthanasios Ziogas, Mariolina Bruno, Roy van der Meel, et al.
Nature Nanotechnology|November 8, 2019
Smart cancer nanomedicineRoy van der Meel, Einar Sulheim, Yang Shi, et al.
Advanced Drug Delivery Reviews|July 5, 2020
Lipid nanoparticle technology for therapeutic gene regulation in the liverDominik Witzigmann, Jayesh A Kulkarni, Jerry Leung, et al.
Advanced Drug Delivery Reviews|July 30, 2020
Nuclear imaging approaches facilitating nanomedicine translationCarlos Pérez-Medina, Abraham J P Teunissen, Ewelina Kluza, et al.
Advanced Drug Delivery Reviews|September 11, 2013
Ligand-targeted particulate nanomedicines undergoing clinical evaluation: current statusRoy van der Meel, Laurens J C Vehmeijer, Robbert J Kok, et al.
Drug Discovery Today|December 29, 2009
Recent advances in molecular imaging biomarkers in cancer: application of bench to bedside technologiesRoy van der Meel, William M Gallagher, Sabrina Oliveira, et al.
Nanomedicine (London, England)|March 30, 2016
Cetuximab treatment alters the content of extracellular vesicles released from tumor cellsSusan M van Dommelen, Roy van der Meel, Wouter W van Solinge, et al.
Langmuir : the ACS Journal of Surfaces and Colloids|January 13, 2021
Characterization of Lipid Nanoparticles Containing Ionizable Cationic Lipids Using Design-of-Experiments ApproachTakeshi Terada, Jayesh A Kulkarni, Ariel Huynh, et al.
Nature Nanotechnology|July 1, 2021
Author Correction: The current landscape of nucleic acid therapeuticsJayesh A Kulkarni, Dominik Witzigmann, Sarah B Thomson, et al.
Pageof 6